Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma

Bortezomib is a first-generation proteasome inhibitor used in the treatment of multiple myeloma (MM). A few reports have linked bortezomib exposure with the development of thrombotic microangiopathy (TMA). We describe a case of biopsy-proven renal thrombotic microangiopathy associated with the use o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Hematol
Autors principals: Van Keer, Jan, Delforge, Michel, Dierickx, Daan, Peerlinck, Kathelijne, Lerut, Evelyne, Sprangers, Ben
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2016
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4884801/
https://ncbi.nlm.nih.gov/pubmed/27293920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6020691
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars